Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q3

6960.TEDINET S100Q3IX
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥93.5bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥132.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥93.1bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥16.1bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥15.9bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥16.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥23.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.3bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥16.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥16.8bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥16.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.6bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥11.6bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥195.2bnat 2022-12-31Cons.Assets
Total assets¥195.5bnat 2022-03-31Cons.Assets
Total assets¥183.2bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥38.6bnat 2022-12-31Cons.Liabilities
Total liabilities¥45.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥156.6bnat 2022-12-31Cons.Net assets
Net assets / equity¥149.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥145.2bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥63.3bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥64.1bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥383.712022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥115.282022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥536.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥382.892021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥135.082021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio80.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio79.3%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥16.1bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2021-04-01 → 2021-12-31¥24.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2021-04-01 → 2021-12-31¥24.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2021-04-01 → 2021-12-31¥3.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥40.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥40.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥8.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥9.3bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥9.3bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2021-04-01 → 2021-12-31¥18.8bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2021-04-01 → 2021-12-31¥18.8bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2021-04-01 → 2021-12-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-12-31¥93.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-12-31¥93.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-12-31¥15.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 372
ItemContextValueUnit
Income taxes deferredPrior1YTDDuration388000000JPY
Income taxes deferredCurrentYTDDuration111000000JPY
Income taxesPrior1YTDDuration5234000000JPY
Income taxesCurrentYTDDuration5271000000JPY
Profit lossPrior1YTDDuration11579000000JPY
Profit lossCurrentYTDDuration11606000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration11579000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration11606000000JPY
Profit lossPrior1YTDDuration11579000000JPY
Profit lossCurrentYTDDuration11606000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration52000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration103000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration117000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration209000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration23000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration31000000JPY
Other comprehensive incomePrior1YTDDuration194000000JPY
Other comprehensive incomeCurrentYTDDuration344000000JPY
Comprehensive incomePrior1YTDDuration11773000000JPY
Comprehensive incomeCurrentYTDDuration11950000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration11773000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration11950000000JPY
Discounted export bill obligationPrior1YearInstant33000000JPY
Discounted export bill obligationCurrentQuarterInstant－JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember18849000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember9250000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember40421000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember24546000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember93068000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration93068000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember18849000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember9250000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember40421000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember24546000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember93068000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration93068000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000PhysiologicalDiagnosticEquipmentReportableSegmentsMember2533000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000PatientMonitoringEquipmentReportableSegmentsMember1473000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000MedicalTreatmentEquipmentReportableSegmentsMember8452000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E02304-000ConsumablesAndOtherProductsReportableSegmentsMember3404000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember15863000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass